United States · FDA National Drug Code directory

Guaifenesin and Pseudoephedrine HCl

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 30142-137_bd1d5672-dce6-47dc-96be-26bce0db708d
Product NDC: 30142-137
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Guaifenesin and Pseudoephedrine HCl
Labeler: KROGER COMPANY
Marketing category: ANDA
Marketing start / end (source format): 20210416
Source listing expiry: 20261231

Source-listed ingredients

GUAIFENESIN — 600 mg/1
PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BLISTER PACK in 1 CARTON (30142-137-12) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 30142-137-12
2 BLISTER PACK in 1 CARTON (30142-137-17) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 30142-137-17

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →